BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 1974706)

  • 1. Intracerebroventricular infusion but not bolus injection of vasopressin increases the cerebrospinal fluid pressure in awake rabbits.
    Sørensen PS; Gyring JA
    Neurol Res; 1990 Jun; 12(2):83-8. PubMed ID: 1974706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intracerebroventricular arginine vasopressin causes intracranial pressure to rise in conscious goats.
    Seckl JR; Lightman SL
    Brain Res; 1987 Oct; 423(1-2):279-85. PubMed ID: 3676810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intracerebroventricular vasopressin reduces CSF absorption rate in the conscious goat.
    Seckl JR; Lightman SL
    Exp Brain Res; 1991; 84(1):173-6. PubMed ID: 1855557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of intracerebroventricular versus intravenous administration of vasopressin on intracranial pressure in the rat.
    Saladin LK; Bruni JE
    Neurol Res; 1993 Jun; 15(3):198-203. PubMed ID: 8103586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebrospinal fluid pressure during cerebroventricular infusion of angiotensin and vasopressin.
    Barbella YR; Keil LC; Wurpel JN; Severs WB
    Exp Neurol; 1983 Nov; 82(2):325-34. PubMed ID: 6628620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Central losartan blocks natriuretic, vasopressin, and pressor responses to central hypertonic NaCl in sheep.
    Mathai ML; Evered MD; McKinley MJ
    Am J Physiol; 1998 Aug; 275(2):R548-54. PubMed ID: 9688692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vasopressin enhances the clearance of beta-endorphin immunoreactivity from rat cerebrospinal fluid.
    Sweep CG; Boomkamp MD; Barna I; Logtenberg AW; Wiegant VM
    Acta Endocrinol (Copenh); 1990 Feb; 122(2):191-200. PubMed ID: 2138399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of changes in the third ventricular CSF tonicity, central and systemic AVP concentrations and water intake.
    Eriksson S; Simon-Oppermann C; Simon E; Gray DA
    Acta Physiol Scand; 1987 Aug; 130(4):575-83. PubMed ID: 3630735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Central injections of arginine vasopressin prolong extinction of active avoidance.
    Koob GF; Dantzer R; Bluthé RM; Lebrun C; Bloom FE; Le Moal M
    Peptides; 1986; 7(2):213-8. PubMed ID: 3737445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of chronic icv infusion of vasopressin on sleep-waking cycle of rats.
    Arnauld E; Bibene V; Meynard J; Rodriguez F; Vincent JD
    Am J Physiol; 1989 Mar; 256(3 Pt 2):R674-84. PubMed ID: 2923256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of arginine vasopressin, acetazolamide, and angiotensin II on CSF pressure at simulated altitude.
    Senay LC; Tolbert DL
    Aviat Space Environ Med; 1984 May; 55(5):370-6. PubMed ID: 6732691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Responses of vasopressin, atrial natriuretic peptide, and blood pressure to central osmotic stimulation.
    Iitake K; Kimura T; Ota K; Shoji M; Inoue M; Ohta M; Sato K; Yamamoto T; Yasujima M; Abe K
    Am J Physiol; 1989 Oct; 257(4 Pt 1):E611-6. PubMed ID: 2529777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reflex effect of vasopressin after blockade of V1 receptors in the area postrema.
    Hasser EM; Bishop VS
    Circ Res; 1990 Aug; 67(2):265-71. PubMed ID: 2376071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Participation of arginine vasopressin-mediated and adrenergic system-mediated mechanisms in the hypertension induced by intracerebroventricular administration of NMDA in freely moving rats.
    Maione S; Vitagliano S; Berrino L; Lampa E; Rossi F
    Neuropharmacology; 1992 Apr; 31(4):403-7. PubMed ID: 1355901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential cardiovascular effects of centrally administered vasopressin in conscious Long Evans and Brattleboro rats.
    Harland D; Gardiner SM; Bennett T
    Circ Res; 1989 Oct; 65(4):925-33. PubMed ID: 2791228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in amino acid levels in rat plasma, cisternal cerebrospinal fluid, and brain tissue induced by intravenously infused arginine-vasopressin.
    Reichel A; Begley DJ; Ermisch A
    Peptides; 1995; 16(5):965-71. PubMed ID: 7479343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic intracerebral infusions of vasopressin and vasopressin antagonist modulate behavioral effects of interleukin-1 in rat.
    Bluthé RM; Dantzer R
    Brain Res Bull; 1992 Dec; 29(6):897-900. PubMed ID: 1473021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mediation of the stress-induced prolactin release by hypothalamic histaminergic neurons and the possible involvement of vasopressin in this response.
    Kjaer A; Knigge U; Olsen L; Vilhardt H; Warberg J
    Endocrinology; 1991 Jan; 128(1):103-10. PubMed ID: 1986913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Central administration of corticotrophin releasing hormone but not arginine vasopressin stimulates the secretion of luteinizing hormone in rams in the presence and absence of testosterone.
    Tilbrook AJ; Canny BJ; Stewart BJ; Serapiglia MD; Clarke IJ
    J Endocrinol; 1999 Aug; 162(2):301-11. PubMed ID: 10425469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Central nervous system mechanisms involved in inhibition of renal sympathetic nerve activity induced by arginine vasopressin.
    Suzuki S; Takeshita A; Imaizumi T; Hirooka Y; Yoshida M; Ando S; Nakamura M
    Circ Res; 1989 Nov; 65(5):1390-9. PubMed ID: 2805250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.